National Health (NHI) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $1.15
- EPS estimate
- $0.84
- EPS surprise
- +36.37%
- Revenue surprise
- −1.02%
- Revenue
- $71.4M
- Revenue estimate
- $72.1M
- Reported
- Aug 10, 2026
National Health reported Q2 2026 results on August 10, 2026. Earnings per share were $1.15, ahead of the $0.84 estimate by 36.37%. Revenue was $71.4 million, 1.02% below the $72.1 million consensus. Compared with Q2 2025, EPS rose about 46% from $0.79, while revenue rose about 2% from $70.3 million.
The $1.15 is the highest quarterly EPS in the table. The first half of 2026 adds up to $1.97 per share, about 29% more than the same period a year earlier. Annual EPS was $1.47 in 2022, then about doubled to $3.13 in 2023 and held at $3.12 in 2024. Q4 2022, at $0.04, is the low in the table. The table has no Q4 2025 row, so it shows no full total for 2025. Quarterly revenue has stayed between about $60 million and $73 million since 2023. National Health beat the EPS estimate in 11 of the 20 quarters shown and in 6 of the last 8, but revenue topped the consensus only 7 times.
Q3 results came between November 5 and November 8 in each of the past five years. That points to early November 2026 for the next report.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 10, 2026 | $0.84 | $1.15 | +36.37% | $71.4M | SEC |
| Q1 2026 | May 4, 2026 | $0.85 | $0.82 | −3.98% | $73.2M | SEC |
| Q3 2025 | Nov 6, 2025 | $0.68 | $0.69 | +0.83% | $62.2M | SEC |
| Q2 2025 | Aug 6, 2025 | $0.75 | $0.79 | +5.52% | $70.3M | SEC |
| Q1 2025 | May 5, 2025 | $0.73 | $0.74 | +1.43% | $68.9M | SEC |
| Q4 2024 | Feb 25, 2025 | $0.74 | $0.95 | +28.38% | $65.8M | SEC |
| Q3 2024 | Nov 5, 2024 | $0.73 | $0.65 | −11.07% | $63.3M | SEC |
| Q2 2024 | Aug 6, 2024 | $0.72 | $0.81 | +11.99% | $65.8M | SEC |
| Q1 2024 | May 6, 2024 | $0.68 | $0.71 | +4.75% | $62.2M | SEC |
| Q4 2023 | Feb 20, 2024 | $0.68 | $0.74 | +8.71% | $60.7M | SEC |
| Q3 2023 | Nov 7, 2023 | $0.72 | $0.68 | −5.56% | $62.3M | SEC |
| Q2 2023 | Aug 8, 2023 | $0.69 | $0.92 | +33.33% | $61.0M | SEC |
| Q1 2023 | May 9, 2023 | $0.66 | $0.79 | +19.70% | $65.3M | SEC |
| Q4 2022 | Feb 21, 2023 | $0.83 | $0.04 | −95.18% | $53.8M | SEC |
| Q3 2022 | Nov 8, 2022 | $0.77 | $0.78 | +1.30% | $59.4M | SEC |
| Q2 2022 | Aug 8, 2022 | $0.73 | $0.47 | −35.62% | $40.0M | SEC |
| Q1 2022 | May 9, 2022 | $0.63 | $0.18 | −71.43% | $64.6M | SEC |
| Q4 2021 | Feb 22, 2022 | $0.93 | $0.14 | −84.86% | $69.7M | SEC |
| Q3 2021 | Nov 8, 2021 | $0.87 | $0.67 | −22.54% | $67.0M | SEC |
| Q2 2021 | Aug 9, 2021 | $0.89 | $0.85 | −4.49% | $68.4M | SEC |
Quarterly revenue
Frequently asked questions
When did National Health (NHI) last report earnings?
National Health last reported on Aug 10, 2026, covering fiscal Q2 2026.
Did NHI beat earnings estimates?
Yes. National Health reported EPS of $1.15 for Q2 2026 against a $0.84 estimate — a 36.37% beat.
How much revenue did NHI report last quarter?
National Health reported $71.4M in revenue for Q2 2026, against a consensus estimate of $72.1M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.